|
Pitango, an existing investor, was joined by Medtronic and Medica3 as new investors in the company.
Guy Ezekiel, MD CEO of Ventor said: ג€Ventor intends to use the capital raised for initiating its clinical trials and further expending its portfolio of transcatheter aortic valve replacement productsג€ | 
